Package 59762-2440-7

{"route": ["ORAL"], "spl_id": "951190c2-78a4-4d2f-881c-099ea0397abf", "openfda": {"upc": ["0359762241078", "0359762248077", "0359762244079", "0359762242075"], "unii": ["86P6PQK0MU"], "rxcui": ["197625", "197626", "197627", "197628"], "spl_set_id": ["6b887aa5-5edf-48c5-a480-dea8c35afa9d"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (59762-2440-7)", "package_ndc": "59762-2440-7", "marketing_end_date": "20270131", "marketing_start_date": "20230118"}], "brand_name": "Doxazosin", "product_id": "59762-2440_951190c2-78a4-4d2f-881c-099ea0397abf", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "59762-2440", "generic_name": "doxazosin", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "4 mg/1"}], "application_number": "NDA019668", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_end_date": "20270131", "marketing_start_date": "20230118"}